Klotho Neurosciences Statistics
Total Valuation
KLTO has a market cap or net worth of $4.91 million. The enterprise value is $5.08 million.
Important Dates
The next estimated earnings date is Thursday, May 15, 2025, before market open.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KLTO has 28.51 million shares outstanding. The number of shares has increased by 27.21% in one year.
| Current Share Class | 28.51M |
| Shares Outstanding | 28.51M |
| Shares Change (YoY) | +27.21% |
| Shares Change (QoQ) | +63.12% |
| Owned by Insiders (%) | 36.00% |
| Owned by Institutions (%) | 9.31% |
| Float | 13.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.93 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.13, with a Debt / Equity ratio of 0.20.
| Current Ratio | 0.13 |
| Quick Ratio | 0.05 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.54 |
Financial Efficiency
Return on equity (ROE) is -700.07% and return on invested capital (ROIC) is -209.47%.
| Return on Equity (ROE) | -700.07% |
| Return on Assets (ROA) | -148.93% |
| Return on Invested Capital (ROIC) | -209.47% |
| Return on Capital Employed (ROCE) | -457.93% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.05M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.02 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.26 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 38.85 |
| Average Volume (20 Days) | 146,806 |
Short Selling Information
The latest short interest is 45,670, so 0.16% of the outstanding shares have been sold short.
| Short Interest | 45,670 |
| Short Previous Month | 54,199 |
| Short % of Shares Out | 0.16% |
| Short % of Float | 0.33% |
| Short Ratio (days to cover) | 0.08 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.54M |
| Pretax Income | n/a |
| Net Income | -6.15M |
| EBITDA | n/a |
| EBIT | -5.54M |
| Earnings Per Share (EPS) | -$0.32 |
Full Income StatementBalance Sheet
The company has $63,741 in cash and $240,753 in debt, giving a net cash position of -$177,012 or -$0.01 per share.
| Cash & Cash Equivalents | 63,741 |
| Total Debt | 240,753 |
| Net Cash | -177,012 |
| Net Cash Per Share | -$0.01 |
| Equity (Book Value) | 1.19M |
| Book Value Per Share | 0.04 |
| Working Capital | -1.09M |
Full Balance SheetCash Flow
| Operating Cash Flow | -2.95M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |